371 related articles for article (PubMed ID: 16950635)
1. Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli.
Aminian M; Sivam S; Lee CW; Halperin SA; Lee SF
Protein Expr Purif; 2007 Feb; 51(2):170-8. PubMed ID: 16950635
[TBL] [Abstract][Full Text] [Related]
2. Generation of plant-derived recombinant DTP subunit vaccine.
Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
[TBL] [Abstract][Full Text] [Related]
3. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
Boucher P; Sato H; Sato Y; Locht C
Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
[TBL] [Abstract][Full Text] [Related]
6. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
7. [Expression, purification and specific monoclonal antibodies preparation of diphtheria toxin A fragment].
Ouyang J; Wang JW; Wang CX; Guo L; Tuo HZ; Cui T; Hong T
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):689-93. PubMed ID: 15973991
[TBL] [Abstract][Full Text] [Related]
8. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
Williams MD; Rostovtsev A; Narla RK; Uckun FM
Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
[TBL] [Abstract][Full Text] [Related]
9. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.
Gómez-Duarte OG; Galen J; Chatfield SN; Rappuoli R; Eidels L; Levine MM
Vaccine; 1995 Nov; 13(16):1596-602. PubMed ID: 8578848
[TBL] [Abstract][Full Text] [Related]
10. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
Barbieri JT; Armellini D; Molkentin J; Rappuoli R
Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.
Abomoelak B; Huygen K; Kremer L; Turneer M; Locht C
Infect Immun; 1999 Oct; 67(10):5100-5. PubMed ID: 10496883
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
Mazzantini RP; Miyaji EN; Dias WO; Sakauchi D; Nascimento AL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Vaccine; 2004 Jan; 22(5-6):740-6. PubMed ID: 14741167
[TBL] [Abstract][Full Text] [Related]
15. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of tetanus toxin fragment C-thioredoxin fusion protein in Escherichia coli.
Ribas AV; Ho PL; Tanizaki MM; Raw I; Nascimento AL
Biotechnol Appl Biochem; 2000 Apr; 31(2):91-4. PubMed ID: 10744952
[TBL] [Abstract][Full Text] [Related]
17. [Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein].
Yao LL; Wang JN; Huang YZ; Guo LY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1319-25. PubMed ID: 16982446
[TBL] [Abstract][Full Text] [Related]
18. A novel fusion protein diphtheria toxin-stem cell factor (DT-SCF)-purification and characterization.
Potala S; Verma RS
Appl Biochem Biotechnol; 2010 Nov; 162(5):1258-69. PubMed ID: 20084469
[TBL] [Abstract][Full Text] [Related]
19. [Soluble expression, purification and characterization of Bm K IT in Escherichia coli by intein-mediated system].
Xu CG; Fan XJ; Zhang ZY; Fu YJ; Liang AH
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):989-94. PubMed ID: 18257224
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and purification of an immunologically reactive His-BIV capsid fusion protein.
Betemps D; Mallet F; Cheynet V; Baron T
Protein Expr Purif; 1999 Apr; 15(3):258-64. PubMed ID: 10092485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
